CEO Message

Thank you for visiting GeneX Inc.

Since its establishment in 2013, GeneX Inc has continuously
discovered innovative products from excellent foreign companies
such as the United States and introduced them to university
hospitals and general hospitals in Korea.

GeneX focus on molecular diagnostic products and
in vitro diagnostic reagents (IVDs). Recently, We also started
manufacturing and selling in vitro diagnostic medical device
based on biochemistry and immunity.

GeneX is a young company that strives to realize
the dreams of individual employees with the development
of the company. I will try to fulfill my transparent management
and social responsibility with young passion.

Please continue to pay attention and encouragement to
GeneX Inc which is taking a leap forward.

Thank you.

CEO Kim Min Ho.

History

• Dec. 2022 Certificated for ISO13485:2016
• Nov. 2022 Expansion of manufacturing facility
• Jun. 2022 Establishment of GeneX R&D Center
• Mar. 2021 Acquired license for manufacturing in vitro diagnostic medical devices business
• Feb. 2021 Certificated for In Vitro Diagnostic Medical Device KGMP – Devices for Clinical Chemistry
• Jan. 2021 Certificated for In Vitro Diagnostic Medical Device KGMP – Devices for Clinical Immunology
• Sep. 2020 Establishment of biochemical diagnosis business department of GeneX, Inc.
• 000.2018 Awarded “Cepheid HAI CRE Product Campion”
• 000.2017 Awarded “Cepheid APAC Regional Channel Partner of the year”
• Jun. 2017 Relocation of the office
• 000.2015 Awarded “Cepheid Outstanding Sales Performance”
• 000.2013 Awarded “Cepheid Outstanding Revenue Growth”
• Apr. 2013 Signed contract for exclusive distributor in Korea with Cepheid
• Apr. 2013 Acquired license for medical device import business
• Feb. 2013 Establishment of GeneX, Inc.